You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
大湖股份(600257.SH):2022年度預虧6000萬至7000萬元
格隆匯 01-30 16:15

格隆匯1月30日丨大湖股份(600257.SH)公佈,預計2022年度實現歸屬於上市公司股東的淨利潤將出現虧損,實現歸屬於上市公司股東的淨利潤預計為-6000萬元到-7000萬元。

2022年歸屬於上市公司股東的扣除非經營性損益的淨利潤預計為-7500萬元到-8500萬元。

公司預計2022年度歸屬於上市公司股東的淨利潤將出現虧損,主要是綜合以下因素的影響:

(一)商譽減值對業績的影響

公司於2020年收購東方華康醫療管理有限公司(“東方華康”)的股權交易,屬於非同一控制下的企業合併,在合併財務報表中確認的商譽為189,204,341.18元。根據中國證監會《會計監管風險提示第8號-商譽減值》的規定,公司對企業合併所形成的商譽進行了減值測試。經公司財務部門的初步評估測算,併購東方華康所形成商譽相關的資產組可回收價值低於其賬面價值,預測2022年計提的歸屬於上市公司股東淨利潤的商譽減值準備的金額約4000萬元。最終商譽減值準備計提的金額由公司聘請的具備證券期貨從業資格的評估機構及審計機構進行評估和審計後確定。

(二)新設立控股子公司對業績的影響

公司2021年7月設立的控股子公司杭州東方華康康復醫院有限公司和杭州金誠護理院有限公司(“杭州兩家醫院”)於2022年6月取得醫療機構執業許可證,於2022年8月才正式開業。因開業時間較短,杭州兩家醫院業務拓展產生的營收還不足以支撐籌備期投入產生的租賃使用權資產折舊費、租賃負債未確認融資費用攤銷、裝修費的攤銷、設備配置等成本費用,預計影響歸屬於上市公司股東的淨利潤約-4500萬元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account